WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 3, 2006, 26(18)

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Next Article 

This Week in The Journal
This Week in The Journal

Formula Cellular/Molecular

Synaptic Sites of Endocannabinoid Synthesis

Takayuki Yoshida, Masahiro Fukaya, Motokazu Uchigashima, Eriko Miura, Haruyuki Kamiya, Masanobu Kano, and Masahiko Watanabe

(see pages 4740–4751)

The retrograde messenger endocannabinoid 2-arachidonoyl-glycerol (2-AG) is produced in postsynaptic cells only to act on CB1 receptors on presynaptic nerve terminals. In this week's Journal, Yoshida et al. examine—very closely—the subcellular localization of the 2-AG production machinery, diacylglycerol lipase-{alpha} (DAGL{alpha}). The authors used immunostaining and immunoelectron microscopy to visualize DAGL{alpha}. Cerebellar Purkinje neurons expressed DAGL{alpha} predominantly on distal dendritic spiny branchlets, with less expression in more proximal, somatodendritic membrane. Interestingly, DAGL{alpha} was concentrated at the base of spine necks but was excluded from spine necks and heads. Hippocampal pyramidal cells expressed DAGL{alpha} in spines as well, but here expression was within spine heads and necks, with little in somatodendritic membrane. In the CA1 subfield, stratum radiatum was more heavily labeled than stratum lacunosum-moleculare. See the paper by Katona et al. in the May 24, 2006 issue for more on this topic.

Formula Development/Plasticity/Repair

Neutralizing NG2 after Spinal Injury

Andrew M. Tan, Mario Colletti, Ann T. Rorai, J. H. Pate Skene, and Joel M. Levine

(see pages 4729–4739)

Axons trying to regenerate after spinal cord injury face a major obstacle in the form of the glial scar. It's not only figuring out what makes axons grow, but also avoiding things that may inhibit growth, such as myelin-associated growth inhibitors, semaphorins, and chondroitin sulfate proteoglycans (CSPGs). This week, Tan et al. tried to take the proteoglycan NG2 out of action. The authors transected rat spinal cords and then treated the animals with neutralizing or non-neutralizing anti-NG2 monoclonal antibodies (mAbs). Antibodies were infused into the spinal cord over several days from gelfoam pledglets. In rats treated with non-neutralizing mAbs, afferent mechanosensory neuron axons usually stopped within the lesion penumbra and failed to enter the core. Neutralizing mAbs, however, allowed the axons to grow through the core of the glial scar. When the sensory nerve was preconditioned with a lesion to stimulate growth, axons grew well past the glial scar and into the white matter.Go


Figure 1
View larger version (142K):
[in this window]
[in a new window]
 
Axons labeled with cholera toxin B subunit (CTB; red) terminated caudal to the edge of a spinal cord lesion after treatment with non-neutralizing NG2 antibodies (top panel). However, treatment with neutralizing NG2 antibodies allowed axons to grow past the lesion core (bottom panel). See the article by Tan et al. for details.

 
Formula Behavioral/Systems/Cognitive

Top-Down Auditory Map Plasticity

Daniel B. Polley, Elizabeth E. Steinberg, and Michael M. Merzenich

(see pages 4970–4982)

During early critical periods, topographical maps are formed in sensory cortex based on dedicated afferent sensory input, a bottom-up organization. By training rats to respond either to frequency or to intensity of the same auditory stimuli, Polley et al. tested whether auditory receptive field plasticity in the adult was also affected by top-down task-dependent factors such as attention. In the authors' protocol, the bottom-up signals remained constant but the top-down focus differed. The proportion of primary auditory cortex (AI) and suprarhinal auditory field (SRAF) dedicated to auditory frequencies in the target range expanded in rats trained in frequency recognition (FR), but not in rats trained in loudness recognition (LR). Conversely, in FR-trained—but not LR-trained—rats, auditory stimuli in the trained decibel range evoked more responses. Perhaps surprising, AI responded as robustly to top-down effects as the SRAF, a "higher" processing center.

Formula Neurobiology of Disease

Refining Abeta Immunotherapy

Marcel Maier, Timothy J. Seabrook, Noel D. Lazo, Liying Jiang, Pritam Das, Christopher Janus, and Cynthia A. Lemere

(see pages 4717–4728)

In a second antibody-based study this week, Maier et al. attempt to refine immunotherapy for Alzheimer's disease (AD). Antibodies raised against Abeta1–42 have shown some promise in clearing Abeta from brain, but some immunized patients developed signs of meningoencephalitis, possibly caused by a T-cell-mediated immune response. To avoid the immune response, the authors created immunogens that included the N terminus (Abeta1–15) but not the C-terminal T-cell reactive site. They immunized wild-type mice intranasally with one of four peptides: a lysine-linked tandem repeat of Abeta1–15; the same peptide linked to a three-amino-acid RGD (Arg-Gly-Asp) cell attachment motif to increase immunogenicity; and each of these coupled to a T1 T-helper cell epitope. These immunogens produced moderate to high antibody titers. Splenocytes collected from immunized mice proliferated upon restimulation with the immunogens but not with full-length Abeta. In the AD model hAPPFAD (human amyloid precursor protein, familial AD) mouse, immunization reduced Abeta plaque load and cerebral Abeta, and improved cognitive behavior.

DOI:





This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-